Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 1220 | 2684 | 38.6 | 71% |
Classes in level above (level 2) |
| ID, lev. above |
Publications | Label for level above |
|---|---|---|
| 411 | 16035 | ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE//XRAY CRYSTALLOG UNIT//CO CRYSTAL |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CO CRYSTAL | Author keyword | 103 | 51% | 5% | 146 |
| 2 | CO CRYSTALS | Author keyword | 61 | 48% | 4% | 94 |
| 3 | CRYSTAL ENGINEERING | Author keyword | 19 | 12% | 6% | 151 |
| 4 | SOLID STATE SUPRAMOL STRUCT CHEM | Address | 15 | 82% | 0% | 9 |
| 5 | PFIZER PHARMACEUT MAT SCI | Address | 15 | 34% | 1% | 36 |
| 6 | PHARMACEUTICAL CO CRYSTALS | Author keyword | 15 | 71% | 0% | 12 |
| 7 | PHARMACEUTICAL COCRYSTAL | Author keyword | 15 | 73% | 0% | 11 |
| 8 | TIANMU | Address | 11 | 34% | 1% | 27 |
| 9 | JIYANG | Address | 10 | 63% | 0% | 10 |
| 10 | SUPRAMOLECULAR HETEROSYNTHON | Author keyword | 8 | 100% | 0% | 5 |
Web of Science journal categories |
Author Key Words |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
|---|---|---|---|---|---|---|---|
| 1 | CO CRYSTAL | 103 | 51% | 5% | 146 | Search CO+CRYSTAL | Search CO+CRYSTAL |
| 2 | CO CRYSTALS | 61 | 48% | 4% | 94 | Search CO+CRYSTALS | Search CO+CRYSTALS |
| 3 | CRYSTAL ENGINEERING | 19 | 12% | 6% | 151 | Search CRYSTAL+ENGINEERING | Search CRYSTAL+ENGINEERING |
| 4 | PHARMACEUTICAL CO CRYSTALS | 15 | 71% | 0% | 12 | Search PHARMACEUTICAL+CO+CRYSTALS | Search PHARMACEUTICAL+CO+CRYSTALS |
| 5 | PHARMACEUTICAL COCRYSTAL | 15 | 73% | 0% | 11 | Search PHARMACEUTICAL+COCRYSTAL | Search PHARMACEUTICAL+COCRYSTAL |
| 6 | SUPRAMOLECULAR HETEROSYNTHON | 8 | 100% | 0% | 5 | Search SUPRAMOLECULAR+HETEROSYNTHON | Search SUPRAMOLECULAR+HETEROSYNTHON |
| 7 | BIS IMIDAZOLES | 6 | 80% | 0% | 4 | Search BIS+IMIDAZOLES | Search BIS+IMIDAZOLES |
| 8 | SUPRAMOLECULAR SYNTHON | 5 | 28% | 1% | 15 | Search SUPRAMOLECULAR+SYNTHON | Search SUPRAMOLECULAR+SYNTHON |
| 9 | PHARMACEUTICAL SALTS | 5 | 55% | 0% | 6 | Search PHARMACEUTICAL+SALTS | Search PHARMACEUTICAL+SALTS |
| 10 | GRAPH SETS | 4 | 67% | 0% | 4 | Search GRAPH+SETS | Search GRAPH+SETS |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | CO CRYSTALS | 461 | 61% | 18% | 495 |
| 2 | PHARMACEUTICAL CO CRYSTALS | 443 | 81% | 10% | 263 |
| 3 | CO CRYSTAL | 168 | 55% | 8% | 212 |
| 4 | SUPRAMOLECULAR SYNTHONS | 100 | 42% | 7% | 185 |
| 5 | PHARMACEUTICAL PHASES | 86 | 76% | 2% | 60 |
| 6 | TRICARBOXYLIC ACIDS | 62 | 85% | 1% | 33 |
| 7 | 1 3 5 CYCLOHEXANETRICARBOXYLIC ACID | 57 | 79% | 1% | 37 |
| 8 | TERNARY COCRYSTALS | 41 | 87% | 1% | 20 |
| 9 | PYRIDINE HYDROGEN BONDS | 40 | 82% | 1% | 23 |
| 10 | COCRYSTAL CONTINUUM | 33 | 100% | 0% | 13 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references | % act. ref. to same field |
|---|---|---|---|---|
| Pharmaceutical Cocrystals and Their Physicochemical Properties | 2009 | 408 | 71 | 82% |
| Conformational Polymorphism | 2014 | 57 | 105 | 30% |
| Pharmaceutical cocrystals and poorly soluble drugs | 2013 | 60 | 139 | 71% |
| The role of cocrystals in pharmaceutical science | 2008 | 254 | 38 | 79% |
| Polymorphism in cocrystals: a review and assessment of its significance | 2014 | 18 | 133 | 75% |
| Packing Problems: High Z' Crystal Structures and Their Relationship to Cocrystals, Inclusion Compounds, and Polymorphism | 2015 | 4 | 242 | 32% |
| The role of co-crystals in pharmaceutical design | 2013 | 43 | 51 | 67% |
| Pharmaceutical co-crystal | 2006 | 463 | 94 | 49% |
| Pharmaceutical cocrystals: An overview | 2011 | 73 | 88 | 73% |
| Crystal engineering: A holistic view | 2007 | 632 | 82 | 38% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | SOLID STATE SUPRAMOL STRUCT CHEM | 15 | 82% | 0.3% | 9 |
| 2 | PFIZER PHARMACEUT MAT SCI | 15 | 34% | 1.3% | 36 |
| 3 | TIANMU | 11 | 34% | 1.0% | 27 |
| 4 | JIYANG | 10 | 63% | 0.4% | 10 |
| 5 | PHARMACEUT ANALYT SOLID STATE CHEM | 7 | 57% | 0.3% | 8 |
| 6 | MAGNET ONANCE SPECT IMAGING | 4 | 67% | 0.1% | 4 |
| 7 | SSCI | 4 | 67% | 0.1% | 4 |
| 8 | CHEM UTILIZAT FO TRY BIOMASS ZHEJIANG P | 4 | 44% | 0.3% | 7 |
| 9 | ANALYT BIOL CHEM IL | 3 | 14% | 0.8% | 21 |
| 10 | SOLID STATE SUPRAMOL STRUCT CHEM UNIT | 3 | 60% | 0.1% | 3 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000246079 | CRYSTAL STRUCTURE PREDICTION//SOLID STATE GRP//MOLECULAR ELECTRIC POTENTIAL |
| 2 | 0.0000157031 | PROTON TRANSFER COMPOUNDS//DADA ARRAY//DNA RNA NUCLEOBASES |
| 3 | 0.0000153172 | ANHYDRATE//HYDRATE//POLYMORPH |
| 4 | 0.0000151674 | FRQNT GREEN CHEM CATALYSIS//TECH CHEM ENVIRONM CHEM ITUC//ALDRICH MAT SCI |
| 5 | 0.0000141971 | MOL SCI BIOTECHNOL BIO 21//PROTON TRANSFER COMPOUNDS//3 5 DINITROSALICYLATE COMPLEX |
| 6 | 0.0000135012 | CRYSTALLINE INCLUSION COMPOUNDS//DIOL HOST//CLATHRATE HOSTS |
| 7 | 0.0000132464 | AMINAL CAGE//1 2 DIAMINO 4 METHYLBENZENE//1 3 6 8 TETRAAZATRICYCLO43113 8UNDECANE |
| 8 | 0.0000127240 | SPECIALTY CHEM TECHNOL DEV//CHLOROCADMATEII//N2S LIGAND |
| 9 | 0.0000113679 | CIENCIAS EXATAS BIOL//STRUCTURE SPECTRA CORRELATION//MELAMINE DIBORATE |
| 10 | 0.0000110863 | CARNIDAZOLE//2 4 HYDROXYPHENYLAZOBENZOIC ACID//CARBONIMIDOTHIOATES |